logo
Interferon-associated retinopathy during the treatment of chronic hepatitis C: a systematic review
Viral hepatitis and the Global Burden of Disease: a need to regroup
Relationship between IL-10 gene −1082A/G and −592C/A polymorphisms and the risk of hepatitis C infection: a meta-analysis
Protein phosphatase 2A impairs IFNα-induced antiviral activity against the hepatitis C virus through the inhibition of STAT1 tyrosine phosphorylation
A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients
Hospitalizations due to hepatitis C in Los Angeles County, 2007–2009: case characteristics and factors associated with mortality
Targeted case finding for hepatitis B using dry blood spot testing in the British–Chinese and South Asian populations of the North-East of England
The effects of nucleoside analogue prophylactic treatment on HBV activation in HBcAb+ patients undergoing immunosuppressive therapy
Evolution of glomerular filtration rate in HIV-infected, HIV–HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate
Reduced ADP-ribosylation by PARP1 natural polymorphism V762A and by PARP1 inhibitors enhance Hepatitis B virus replication
Quantifying current hepatitis C virus incidence in Egypt
Quantifying current hepatitis C virus incidence in Egypt – Response to letter by Miller and Abu-Raddad